MGMT Promoter Methylation Predicts Overall Survival after Chemotherapy for 1p/19q-Codeleted Gliomas

Kinslow, C. J., Rae, A. I., Taparra, K., Kumar, P., Siegelin, M. D., Grinband, J., Gill, B. J. A., McKhann, G. M., Sisti, M. B., Bruce, J. N., Canoll, P. D., Iwamoto, F. M., Horowitz, D. P., Kachnic, L. A., Neugut, A. I., Yu, J. B., Cheng, S. K., & Wang, T. J. C. (2023). MGMT Promoter Methylation Predicts Overall Survival after Chemotherapy for 1p/19q-Codeleted Gliomas. Clinical Cancer Research, 29(21), 4399–4407. https://doi.org/10.1158/1078-0432.ccr-23-1295
Authors:
Connor J Kinslow
Ali I Rae
Kekoa Taparra
Prashanth Kumar
Markus D Siegelin
Jack Grinband
Brian J A Gill
Guy M McKhann
Michael B Sisti
Jeffrey N Bruce
Peter D Canoll
Fabio M Iwamoto
David P Horowitz
Lisa A Kachnic
Alfred I Neugut
James B Yu
Simon K Cheng
Tony J C Wang
Affiliated Authors:
Connor J Kinslow
Prashanth Kumar
Markus D Siegelin
Jack Grinband
Brian J A Gill
Guy M McKhann
Michael B Sisti
Jeffrey N Bruce
Peter D Canoll
Fabio M Iwamoto
David P Horowitz
Lisa A Kachnic
Alfred I Neugut
James B Yu
Simon K Cheng
Tony J C Wang
Subjects:
Glioma (MeSH)
Glioblastoma (MeSH)
Publication Type:
Article
Unique ID:
10.1158/1078-0432.ccr-23-1295
PMID:
Publication Date:
Data Source:
PubMed

Record Created: